Pulmonary Fibrosis Clinical Trials

A listing of Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Inhaled Treprostinil and Placebo for patients with Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Birmingham Alabama 35294

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294-0006

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85013

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating SAR156597 and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale Arizona 85259

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

View More ▼

Tucson Arizona 85723

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

California

La Jolla California 92093

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

La Jolla California 92037

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90073

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

Los Angeles California 90048

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-6984

Patients are needed to participate in a clinical research study of Nintedanib and Pirfenidone to evaluate Idiopathic Pulmonary Fibrosis

Palo Alto California 94305

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis (IPF) or Persistent Cough

Sacramento California 95817

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento California 95817

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

San Francisco California 94143

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

San Francisco California 94116

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305-5236

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305

Patients are needed to participate in a clinical research study of Nintedanib and Pirfenidone to evaluate Idiopathic Pulmonary Fibrosis

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Inhaled Treprostinil and Placebo for patients with Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Denver Colorado 80206

A clinical trial to evaluate treatments using Inhaled Treprostinil and Placebo for patients with Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Plerixafor mobilization of autologous CD117 stem cells for the treatment of COPD, Cystic Fibrosis or Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

View More ▼

Denver Colorado 80206

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Wheat Ridge Colorado 80033

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

Danbury Connecticut

A Phase 4 clinical study for patients with Idiopathic Pulmonary Fibrosis

Hartford Connecticut 06102

A clinical trial to evaluate treatments using Ceftolozane/Tazobactam for patients with Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation or Pseudomonas Aeruginosa Infection

New Haven Connecticut 06520

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06511

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06520

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

New Haven Connecticut 06520

A Phase 2 clinical study for patients with Idiopathic Pulmonary Fibrosis (IPF)

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Florida

UPDATED

Orlando Florida 32803

A clinical trial to evaluate treatments using Inhaled Treprostinil and Placebo for patients with Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Orlando Florida 32803

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Clearwater Florida 33756

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis